#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15342	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2098	725.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1449	1449	C	881	C	820	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27964	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3733	747.4	0	.	n	.	0	T695C	SNP	695	695	T	1108	1108	C	888	C	841	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27964	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3733	747.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	2051	2051	G	894	G	853	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27964	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3733	747.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2384	2384	C	841	C,A	795,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27964	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3733	747.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2458	2458	A	859	A	819	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27964	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3733	747.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3010	3010	C	844	C	798	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27964	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3733	747.4	0	HET	.	.	.	C88A	.	88	88	C	501	501	C	887	C,A	681,176	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1898	folP	855	855	100.0	folP.l15.c4.ctg.1	1656	114.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1109	1111	AGC	198;200;199	A;G;C	186;187;183	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4922	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3490	140.7	1	SNP	p	S91F	1	.	.	271	273	TTC	634	636	TTC	169;168;167	T;T;C	160;157;154	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4922	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3490	140.7	1	SNP	p	G95N	0	.	.	283	285	GGC	646	648	GGC	165;165;165	G;G;C	154;153;152	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4922	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3490	140.7	1	SNP	p	D95G	1	.	.	283	285	GGC	646	648	GGC	165;165;165	G;G;C	154;153;152	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1468	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1317	110.9	1	SNP	p	G45D	0	.	.	133	135	GGC	476	478	GGC	156;155;155	G;G;C	148;148;148	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	812	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	994	81.2	0	.	n	.	0	A197.	DEL	197	197	A	598	598	A	194	A	187	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	192.1	1	SNP	p	D86N	0	.	.	256	258	GAC	545	547	GAC	220;220;219	G;A;C	211;208;210	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	192.1	1	SNP	p	S87R	1	.	.	259	261	CGT	548	550	CGT	217;217;219	C;G;T	208;208;206	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	192.1	1	SNP	p	R87I	0	.	.	259	261	CGT	548	550	CGT	217;217;219	C;G;T	208;208;206	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	192.1	1	SNP	p	R87W	0	.	.	259	261	CGT	548	550	CGT	217;217;219	C;G;T	208;208;206	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5662	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	192.1	1	SNP	p	S88P	0	.	.	262	264	TCC	551	553	TCC	220;217;218	T;C;C	209;209;208	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4036	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2632	152.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1544	1546	GGC	192;189;188	G;G;C	181;178;172	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1244	1246	GCC	196;194;194	G;C;C	185;184;182	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1247	1249	ATG	195;193;189	A;T;G	185;184;179	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1259	1261	ACC	190;192;190	A;C,A;C,A	178;183,1;180,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1259	1261	ACC	190;192;190	A;C,A;C,A	178;183,1;180,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1760	1762	ACC	218;219;220	A;C;C	199;204;209	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1814	1816	GCG	191;190;190	G;C;G	185;182;181	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1814	1816	GCG	191;190;190	G;C;G	185;182;181	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1937	1939	GGT	175;174;175	G;G;T	160;161;160	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1946	1948	AGC	166;163;163	A;G;C	154;154;153	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	167.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1964	1966	CCG	144;151;154	C,G;C,A;G,GGCC	118,7;125,1;125,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	15	6020	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3177	189.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1651	1653	CCG	216;218;216	C;C;G	194;205;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	15	6020	ponA	2397	135	99.26	ponA.l15.c4.ctg.2	135	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2128	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1845	114.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	589	589	C	149	C	143	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1834	168.5	0	.	p	.	0	V47M	NONSYN	139	141	GTG	552	554	ATG	249;252;253	A;T;G	239;241;241	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1834	168.5	0	.	p	.	0	V135L	NONSYN	403	405	GTG	816	818	TTG	272;267;266	T;T;G,A	251;249;249,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1834	168.5	0	.	p	.	0	G190D	NONSYN	568	570	GGC	981	983	GAC	253;254;252	G;A,T;C	239;236,1;237	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1834	168.5	0	.	p	.	0	G210E	NONSYN	628	630	GGA	1041	1043	GAA	230;231;234	G;A;A	219;221;224	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1834	168.5	0	.	p	.	0	A212T	NONSYN	634	636	GCA	1047	1049	ACA	231;230;232	A;C;A	224;222;224	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1834	168.5	1	SNP	p	G120K	1	.	.	358	360	AAG	771	773	AAG	278;275;274	A;A;G	263;262;257	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1834	168.5	1	SNP	p	A121N	1	.	.	361	363	AAC	774	776	AAC	273;273;274	A;A;C	260;262;256	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1834	168.5	1	SNP	p	N121D	0	.	.	361	363	AAC	774	776	AAC	273;273;274	A;A;C	260;262;256	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11952	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4933	241.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1256	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	962	129.1	1	SNP	p	V57M	1	.	.	169	171	ATG	491	493	ATG	266;269;267	A;T;G	257;259;258	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
